French, multinational pharmaceutical company Sanofi SA said on 22 February 2021 that it will provide COVID-19 vaccine manufacturing support to US pharmaceutical company Johnson & Johnson Inc (J&J), Reuters news agency reported on Monday.
Reportedly, once authorised, Sanofi will provide Johnson & Johnson access to the infrastructure and expertise of its vaccine manufacturing plant in Marcy l'Etoile, France, to formulate and fill vials of Johnson & Johnson's Janssen COVID-19 vaccine candidate in 2021.
These vials will be filled at a rate of approximately 12 million doses per month, Sanofi added.
India reports supply of over 36 million doses of COVID-19 vaccines abroad
Health Minster of Taiwan states domestic COVID-19 vaccine could be ready in July 2021
Indonesia's government authorises private COVID-19 vaccination scheme
AMRI to support Pfizer and BioNTech's COVID-19 Vaccine development in the fight against the pandemic
US FDA's vaccine advisers to consider third possible COVID-19 vaccine for US on 26 February 2021
Jubilant Therapeutics collaborates with Boston Children's Hospital